Free Trial
NASDAQ:UTRS

Minerva Surgical (UTRS) Stock Price, News & Analysis

Minerva Surgical logo

About Minerva Surgical Stock (NASDAQ:UTRS)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
293 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Minerva Surgical, Inc. is a medical device company focused on women’s health. The company develops and commercializes technologies intended to diagnose and treat conditions affecting the uterus, with an emphasis on abnormal uterine bleeding, a common condition that can significantly affect quality of life.

Its product portfolio includes the Minerva ES Endometrial Ablation System, which uses controlled energy to treat heavy menstrual bleeding, and the Symphion System, a hysteroscopic tissue-removal device used in procedures involving uterine fibroids and polyps. The company has also offered the Genesys HTA System, an endometrial ablation technology designed for use in treating abnormal uterine bleeding.

Minerva Surgical sells its products primarily through healthcare providers, hospitals, and surgical facilities, serving the U.S. market and select international markets. The company was founded in 2008 and is headquartered in Redwood City, California. Its business has historically centered on providing less-invasive alternatives to more extensive surgical procedures in gynecology.

AI Generated. May Contain Errors.

Receive UTRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Minerva Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTRS Stock News Headlines

Minerva Surgical Inc.
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
Cigar Lake Flooded Again Uranium Supply Shock Repeats
In 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This past May, flooding hit the same complex again, and in July Cigar Lake went down a second time, disrupting the world's largest high-grade uranium mine. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
Minerva Surgical Inc UTRS
Minerva Surgical Reports Third Quarter 2023 Financial Results
See More Headlines

UTRS Stock Analysis - Frequently Asked Questions

Minerva Surgical, Inc. (NASDAQ:UTRS) released its quarterly earnings results on Wednesday, December, 1st. The company reported ($23.00) EPS for the quarter, missing the consensus estimate of ($8.80) by $14.20. The business earned $12.51 million during the quarter, compared to the consensus estimate of $12.23 million.

Minerva Surgical's stock reverse split on Monday, October 2nd 2023.The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Minerva Surgical (UTRS) raised $100 million in an IPO on Friday, October 22nd 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Minerva Surgical investors own include Airbnb (ABNB), Absci (ABSI), Adicet Bio (ACET), Affimed (AFMD), Allied Healthcare Products (AHPI), Centurion Acquisition (ALF) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
12/01/2021
Today
11/03/2026
Next Earnings (Estimated)
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:UTRS
CIK
1452965
Fax
N/A
Employees
174
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$51.69 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,880,000
Free Float
8,124,000
Market Cap
$1 thousand
Optionable
Not Optionable
Beta
2.40

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:UTRS) was last updated on 11/2/2026 by MarketBeat.com Staff.
From Our Partners